NCT02792998View on ClinicalTrials.gov

A Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Healthy
Interventions
DRUG

IW-1701

IW-1701 Tablet

DRUG

Placebo

Matching Placebo Tablet

Trial Locations (1)

78209

ICON Early Phase Unit, San Antonio

Sponsors
All Listed Sponsors
lead

Cyclerion Therapeutics

INDUSTRY